Structural modifications toward improved lead-203/lead-212 peptide-based image-guided alpha-particle radiopharmaceutical therapies for neuroendocrine tumors.
Journal Information
Full Title: Eur J Nucl Med Mol Imaging
Abbreviation: Eur J Nucl Med Mol Imaging
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Nuclear Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Funding: This work was partially supported by grants awarded by the US National Institutes of Health, National Cancer Institute R44CA268314; R44CA250872; R44CA254613; 1R01CA243014; 1P50CA174521. Authors M. Li, F.L. Johnson, N. Baumhover, D. Liu, E.A, Sagastume, B.M. Marks, and M.K. Schultz are employees of Perspective Therapeutics, which provided partial research support for these studies."
"Funding This work was partially supported by grants awarded by the US National Institutes of Health, National Cancer Institute R44CA268314; R44CA250872; R44CA254613; 1R01CA243014; 1P50CA174521. Authors M. Li, F.L. Johnson, N. Baumhover, D. Liu, E.A, Sagastume, B.M. Marks, and M.K. Schultz are employees of Perspective Therapeutics, which provided partial research support for these studies."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025